References
- Volm M. Prognostic implications of DNA aneuploidy and proliferative activity in solid humans tumors: a review. Tumor Diagn Ther 1990; 10: 229–32
- Hirsh SM, DuCanto J, Caldarelli DD, Hutchinson JC, Coon JS. Nucleolar organizer regions in squamous cell carcinoma of the head and neck. Laryngoscope 1992; 102: 39–44
- Bockmuhl U, Bockmuhl F, Dimmer V, Kunze KD. “Nucleolar organizer regions” as a factor for the prognosis of laringeal cancer?. Laringorhinootologie 1992; 71: 137–41
- Xie X, Clausen OP, De Angelis P, Boysen M. Bax expression has prognostic significance that is enhanced when combined with AgNOR counts in glottic carcinomas. Br J Cancer 1998; 78: 100–5
- Klatka J, Skomra D. Nucleolar organizer regions in laryngeal cancer. Ann Univ Mariae Curie Sklodowska (Med) 2001; 56: 417–21
- Pulkkinen JO, Klemi P, Martikainen P, Grenman R. Apoptosis in situ, p53, bcl-2 and AgNOR counts as prognostic factors in laryngeal carcinoma. Anticancer Res 1999; 19: 703–7
- Cappiello J, Nicolai P, Antonelli AR, Facchetti F, Cadei M, Cornacchiari A, et al. DNA index, cellular proliferative activity and nucleolar organizer regions in cancers of larynx. Eur Arch Otorhinolaryngol 1995; 252: 353–8
- Struikmans H, Rutgers DH, Hordijk GJ, Slootwen PJ, van der Twell I, Battermann JJ. Interrelationships of DNA-ploidy and cell proliferation markers with T-stage and N-stage in primary laryngeal tumors. Int J Radiat Oncol Biol Phys 1998; 40: 303–8
- Matturry L, Biondo B, Tamplenizza P, Ottaviani A, Lavezzi AM. DNA content and thymidine labeling index correlate with prognosis in squamous cell carcinoma of the larynx. Cancer Detect Prev 1997; 21: 319–25
- Russo A, Bazan V, Gebbia N, Pizzolanti G, Tumminello FM, Dardanoni G, et al. Flow cytometric DNA analysis and lysosomal cathepsin B and L in locally advanced laryngeal cancer. Cancer 1995; 76: 1757–64
- Gregg CM, Beals TE, McClatchy KM, Fisher SG, Wolf GT. DNA content and tumor response to induction chemotherapy in patients with advanced laryngeal squamous cell carcinoma. Otorhingol Head Neck Surg 1993; 108: 728–31
- Resnick JM, Uhland D, Niehans GA, Gapany M, Adams G, Knapp P, et al. Cervical lymph node status and survival in laryngeal carcinoma: prognostic factors. Arch Otolaryngol Head Neck Surg 1995; 104: 685
- Yamamoto Y, Itoh T, Saka T, Sakakura A, Takahashi H. Prognostic value of nucleolar organizer regions in supraglottic carcinoma. Auris Nasus Larynx 1997; 24: 85–90
- Yamamoto Y, Itoh T, Saka T, Sakakura A, Takahashi H. Nucleolar organizer regions in glottic carcinoma: comparison of DNA cytofluorometry and clinicopathological analysis. Eur Arch Otorhinolaryngol 1995; 252: 353–8
- El-Naggar AK, Lopez-Varela V, Luna MA, Weber R, Batsakis JG. Intratumoral DNA content heterogeneity in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1992; 118: 169–73
- Vindelov LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometry DNA analysis. Cytometry 1983; 3: 323–7
- Tytor M, Wingren S, Olofsson J. Heterogeneity of squamous cell carcinomas of the oral cavity studied by flow cytometry. Pathol Res Pract 1991; 187: 30–5
- Seiwerth, S, Ćorić, M, Bumber, Ž, Aralica, G, Konjevoda, P, Ðanić, D, et al. Potential prognostic significance of AgNOR and DNA content in laryngeal cancer. Electronic Journal of Pathology and Histology 2001;7:07–11
- Thomas GR, Nadiminti H, Regalado J. Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int J Exp Pathol 2005; 86: 347–63
- Jacob R, Welkobosky HJ, Mann WJ, Hofken F, Diensen HP, Freije JE. Heterogeneity of squamous cell carcinomas of the head and neck – analysis of tumor biologic factors and proliferation rates. Laryngoscope 1996; 106: 1170–5
- Veltman JA, Hopman AHN, van der Vlies SA, Bot FJ, Ramaekers FCS, Manni JJ. Double target fluorescence in situ hybridization distinguishes multiple genetically aberrant clones in head and neck squamous cell carcinoma. Cytometry 1998; 34: 113–20